Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-04-17 Sale | 2025-04-21 4:04 pm | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 108 | $0.978 | $106 | 370,218 (Direct) | View |
| 2025-04-17 Sale | 2025-04-21 4:03 pm | Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer | 8 | $0.964 | $8 | 481,702 (Direct) | View |
| 2025-03-18 Sale | 2025-03-19 4:03 pm | Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer | 3,535 | $1.483 | $5,242 | 481,710 (Direct) | View |
| 2025-03-18 Sale | 2025-03-19 4:02 pm | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 2,433 | $1.487 | $3,618 | 370,326 (Direct) | View |
| 2025-03-18 Sale | 2025-03-19 4:02 pm | Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO | 13,047 | $1.504 | $19,623 | 1,571,962 (Direct) | View |
| 2025-02-19 Sale | 2025-02-20 4:50 pm | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 239 | $1.868 | $446 | 159,759 (Direct) | View |
| 2025-02-19 Sale | 2025-02-20 4:50 pm | Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer | 11 | $1.86 | $20 | 240,671 (Direct) | View |
| 2025-01-17 Sale | 2025-01-21 4:38 pm | Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer | 9 | $2.265 | $20 | 240,682 (Direct) | View |
| 2025-01-17 Sale | 2025-01-21 4:37 pm | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 123 | $2.26 | $278 | 159,998 (Direct) | View |
| 2024-12-17 Sale | 2024-12-18 4:14 pm | Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer | 3,245 | $2.424 | $7,866 | 240,691 (Direct) | View |
| 2024-12-17 Sale | 2024-12-18 4:13 pm | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 2,234 | $2.429 | $5,426 | 160,121 (Direct) | View |
| 2024-12-17 Sale | 2024-12-18 4:12 pm | Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO | 12,447 | $2.466 | $30,694 | 739,819 (Direct) | View |
| 2024-11-19 Sale | 2024-11-20 4:10 pm | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 197 | $2.165 | $427 | 162,355 (Direct) | View |
| 2024-10-17 Sale | 2024-10-18 4:08 pm | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 107 | $2.119 | $227 | 162,552 (Direct) | View |
| 2024-09-17 Sale | 2024-09-18 4:12 pm | Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO | 14,550 | $1.796 | $26,132 | 752,266 (Direct) | View |
| 2024-09-17 Sale | 2024-09-18 4:11 pm | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 2,608 | $1.783 | $4,650 | 162,659 (Direct) | View |
| 2024-08-19 Sale | 2024-08-20 4:03 pm | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 211 | $1.946 | $411 | 165,267 (Direct) | View |
| 2024-07-17 Sale | 2024-07-19 08:30 am | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 108 | $2.587 | $279 | 165,478 (Direct) | View |
| 2024-07-17 Sale | 2024-07-19 08:29 am | Esperion Therapeutics Inc. | ESPR | Foody Joanne M. Chief Medical Officer | 917 | $2.599 | $2,383 | 272,862 (Direct) | View |
| 2024-06-18 Sale | 2024-06-20 4:20 pm | Esperion Therapeutics Inc. | ESPR | Foody Joanne M. Chief Medical Officer | 3,285 | $2.867 | $9,418 | 273,779 (Direct) | View |
| 2024-06-18 Sale | 2024-06-20 4:16 pm | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 2,540 | $2.856 | $7,254 | 165,586 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-05-29 Option Award | 2025-06-02 4:10 pm | N/A 2035-05-29 | Esperion Therapeutics Inc. | ESPR | CARROLL J MARTIN Director | 77,000 | $0 | 141,650 (Direct) | View |
| 2025-05-29 Option Award | 2025-06-02 4:10 pm | N/A 2035-05-29 | Esperion Therapeutics Inc. | ESPR | Fischer Seth H. Z. Director | 77,000 | $0 | 105,150 (Direct) | View |
| 2025-05-29 Option Award | 2025-06-02 4:09 pm | N/A 2035-05-29 | Esperion Therapeutics Inc. | ESPR | Hoffman Robert E. Director | 12,320 | $0 | 12,320 (Direct) | View |
| 2025-05-29 Option Award | 2025-06-02 4:08 pm | N/A 2035-05-29 | Esperion Therapeutics Inc. | ESPR | ROCAMBOLI STEPHEN Director | 77,000 | $0 | 113,261 (Direct) | View |
| 2025-05-29 Option Award | 2025-06-02 4:08 pm | N/A 2035-05-29 | Esperion Therapeutics Inc. | ESPR | Shepard Jay Director | 77,000 | $0 | 128,599 (Direct) | View |
| 2025-05-29 Option Award | 2025-06-02 4:07 pm | N/A 2035-05-29 | Esperion Therapeutics Inc. | ESPR | VITULLO NICOLE Director | 88,000 | $0 | 88,000 (Direct) | View |
| 2025-05-29 Option Award | 2025-06-02 4:06 pm | N/A 2035-05-29 | Esperion Therapeutics Inc. | ESPR | Woody Tracy M Director | 88,000 | $0 | 88,000 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-02 4:19 pm | N/A 2035-04-01 | Esperion Therapeutics Inc. | ESPR | Hoffman Robert E. Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2025-03-14 Option Award | 2025-03-17 5:17 pm | N/A 2035-03-14 | Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO | 1,593,000 | $0 | 2,338,009 (Direct) | View |
| 2025-03-14 Option Award | 2025-03-17 5:16 pm | N/A 2035-03-14 | Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer | 451,000 | $0 | 698,245 (Direct) | View |
| 2025-03-14 Option Award | 2025-03-17 5:16 pm | N/A 2035-03-14 | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 404,000 | $0 | 563,759 (Direct) | View |
| 2025-03-14 Option Award | 2025-03-17 5:15 pm | N/A 2035-03-14 | Esperion Therapeutics Inc. | ESPR | Looker Benjamin General Counsel | 425,000 | $0 | 608,663 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-24 4:18 pm | N/A 2034-05-23 | Esperion Therapeutics Inc. | ESPR | CARROLL J MARTIN Director | 55,500 | $0 | 97,150 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-24 4:18 pm | N/A 2034-05-23 | Esperion Therapeutics Inc. | ESPR | Fischer Seth H. Z. Director | 55,500 | $0 | 60,650 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-24 4:17 pm | N/A 2034-05-23 | Esperion Therapeutics Inc. | ESPR | Fuhrman Alan Director | 55,500 | $0 | 85,904 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-24 4:16 pm | N/A 2034-05-23 | Esperion Therapeutics Inc. | ESPR | GOTTO ANTONIO M JR MD D PHIL Director | 55,500 | $0 | 84,099 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-24 4:15 pm | N/A 2034-05-23 | Esperion Therapeutics Inc. | ESPR | ROCAMBOLI STEPHEN Director | 55,500 | $0 | 68,761 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-24 4:14 pm | N/A 2034-05-23 | Esperion Therapeutics Inc. | ESPR | Shepard Jay Director | 55,500 | $0 | 84,099 (Direct) | View |